These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 16243255)

  • 1. Specific enzyme identified that snips APP into beta-amyloid.
    Senior K
    Drug Discov Today; 2005 Nov; 10(21):1408. PubMed ID: 16243255
    [No Abstract]   [Full Text] [Related]  

  • 2. [Secretases as targets for the treatment of Alzheimer's disease].
    Luo HM; Gu F
    Sheng Li Ke Xue Jin Zhan; 2003 Apr; 34(2):189-92. PubMed ID: 12889164
    [No Abstract]   [Full Text] [Related]  

  • 3. A substrate-based difluoro ketone selectively inhibits Alzheimer's gamma-secretase activity.
    Wolfe MS; Citron M; Diehl TS; Xia W; Donkor IO; Selkoe DJ
    J Med Chem; 1998 Jan; 41(1):6-9. PubMed ID: 9438016
    [No Abstract]   [Full Text] [Related]  

  • 4. Secretase inhibitors for Alzheimer's disease: challenges of a promiscuous protease.
    Pollack SJ; Lewis H
    Curr Opin Investig Drugs; 2005 Jan; 6(1):35-47. PubMed ID: 15675602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mice deficient in BACE1, the Alzheimer's beta-secretase, have normal phenotype and abolished beta-amyloid generation.
    Luo Y; Bolon B; Kahn S; Bennett BD; Babu-Khan S; Denis P; Fan W; Kha H; Zhang J; Gong Y; Martin L; Louis JC; Yan Q; Richards WG; Citron M; Vassar R
    Nat Neurosci; 2001 Mar; 4(3):231-2. PubMed ID: 11224535
    [No Abstract]   [Full Text] [Related]  

  • 6. Amyloidogenic processing of beta-amyloid precursor protein in intracellular compartments.
    Vetrivel KS; Thinakaran G
    Neurology; 2006 Jan; 66(2 Suppl 1):S69-73. PubMed ID: 16432149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The complex enzymic process yielding beta-amyloid protein in Alzheimer's disease].
    Sela B
    Harefuah; 2000 Jul; 139(1-2):42-7. PubMed ID: 10979452
    [No Abstract]   [Full Text] [Related]  

  • 8. Amyloid-beta precursor protein processing in neurodegeneration.
    Wilquet V; De Strooper B
    Curr Opin Neurobiol; 2004 Oct; 14(5):582-8. PubMed ID: 15464891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A lipid boundary separates APP and secretases and limits amyloid beta-peptide generation.
    Kaether C; Haass C
    J Cell Biol; 2004 Dec; 167(5):809-12. PubMed ID: 15583026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and activity of beta-site amyloid precursor protein cleaving enzyme in Alzheimer's disease.
    Johnston JA; Liu WW; Todd SA; Coulson DT; Murphy S; Irvine GB; Passmore AP
    Biochem Soc Trans; 2005 Nov; 33(Pt 5):1096-100. PubMed ID: 16246054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BACE inhibitor reduces APP-beta-C-terminal fragment accumulation in axonal swellings of okadaic acid-induced neurodegeneration.
    Yoon SY; Choi JE; Yoon JH; Huh JW; Kim DH
    Neurobiol Dis; 2006 May; 22(2):435-44. PubMed ID: 16480887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloid-lowering isocoumarins are not direct inhibitors of gamma-secretase.
    Esler WP; Das C; Campbell WA; Kimberly WT; Kornilova AY; Diehl TS; Ye W; Ostaszewski BL; Xia W; Selkoe DJ; Wolfe MS
    Nat Cell Biol; 2002 May; 4(5):E110-1; author reply E111-2. PubMed ID: 11988746
    [No Abstract]   [Full Text] [Related]  

  • 13. [Alzheimer's disease: focus on beta-amyloid and gamma-secretase].
    Iwatsubo T
    Tanpakushitsu Kakusan Koso; 2004 May; 49(7 Suppl):1086-90. PubMed ID: 15168534
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of huperzine A on amyloid precursor protein processing and beta-amyloid generation in human embryonic kidney 293 APP Swedish mutant cells.
    Peng Y; Jiang L; Lee DY; Schachter SC; Ma Z; Lemere CA
    J Neurosci Res; 2006 Sep; 84(4):903-11. PubMed ID: 16862548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral administration of a potent and selective non-peptidic BACE-1 inhibitor decreases beta-cleavage of amyloid precursor protein and amyloid-beta production in vivo.
    Hussain I; Hawkins J; Harrison D; Hille C; Wayne G; Cutler L; Buck T; Walter D; Demont E; Howes C; Naylor A; Jeffrey P; Gonzalez MI; Dingwall C; Michel A; Redshaw S; Davis JB
    J Neurochem; 2007 Feb; 100(3):802-9. PubMed ID: 17156133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. sorLA: sorting out APP.
    Shah S; Yu G
    Mol Interv; 2006 Apr; 6(2):74-6, 58. PubMed ID: 16565469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alzheimer's disease. Bad for the heart, bad for the mind?
    Marx J
    Science; 2001 Oct; 294(5542):508-9. PubMed ID: 11641483
    [No Abstract]   [Full Text] [Related]  

  • 18. A novel beta-site amyloid precursor protein cleaving enzyme (BACE) isoform regulated by nonsense-mediated mRNA decay and proteasome-dependent degradation.
    Tanahashi H; Tabira T
    Neurosci Lett; 2007 Nov; 428(2-3):103-8. PubMed ID: 17961921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LRRTM3 promotes processing of amyloid-precursor protein by BACE1 and is a positional candidate gene for late-onset Alzheimer's disease.
    Majercak J; Ray WJ; Espeseth A; Simon A; Shi XP; Wolffe C; Getty K; Marine S; Stec E; Ferrer M; Strulovici B; Bartz S; Gates A; Xu M; Huang Q; Ma L; Shughrue P; Burchard J; Colussi D; Pietrak B; Kahana J; Beher D; Rosahl T; Shearman M; Hazuda D; Sachs AB; Koblan KS; Seabrook GR; Stone DJ
    Proc Natl Acad Sci U S A; 2006 Nov; 103(47):17967-72. PubMed ID: 17098871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An inflammatory drug prospect.
    De Strooper B; König G
    Nature; 2001 Nov; 414(6860):159-60. PubMed ID: 11700538
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.